MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsyRyo Ogawa, Kazuo Fujihara, Ichiro Nakashima et al.|Neurology Neuroimmunology & Neuroinflammation|2017Cited by 432
CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implicationsKimihiko Kaneko, Masashi Aoki, Yuji Hashimoto et al.|Journal of Neurology Neurosurgery & Psychiatry|2018Cited by 199
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel Whittam, Brigitte Wildemann, Álvaro Cobo‐Calvo et al.|Multiple Sclerosis and Related Disorders|2020Cited by 179
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study: Table 1Tetsuya Akaishi, Masashi Aoki, Douglas Kazutoshi Sato et al.|Journal of Neurology Neurosurgery & Psychiatry|2015Cited by 141
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodiesKimihiko Kaneko, Masashi Aoki, Douglas Kazutoshi Sato et al.|Journal of Neurology Neurosurgery & Psychiatry|2016Cited by 108